KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-cash Items (2020 - 2024)

GoodRx Holdings (GDRX) has disclosed Non-cash Items for 5 consecutive years, with $4.4 million as the latest value for Q4 2024.

  • Quarterly Non-cash Items rose 21363.41% to $4.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2024, up 21363.41% year-over-year, with the annual reading at $4.4 million for FY2024, 21363.41% up from the prior year.
  • Non-cash Items hit $4.4 million in Q4 2024 for GoodRx Holdings, up from $20500.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $680.5 million in Q1 2021 to a low of $20500.0 in Q4 2023.
  • Historically, Non-cash Items has averaged $170.4 million across 5 years, with a median of $49.4 million in 2020.
  • Biggest five-year swings in Non-cash Items: crashed 99.92% in 2023 and later soared 21363.41% in 2024.
  • Year by year, Non-cash Items stood at $341.9 million in 2020, then changed by 0.0% to $341.9 million in 2021, then plummeted by 92.72% to $24.9 million in 2022, then plummeted by 99.92% to $20500.0 in 2023, then skyrocketed by 21363.41% to $4.4 million in 2024.
  • Business Quant data shows Non-cash Items for GDRX at $4.4 million in Q4 2024, $20500.0 in Q4 2023, and $24.9 million in Q4 2022.